Mayo Clinic

Migration, Crosslink

📖

Mayo Clinic

active

wiki page Created: 2026-04-02T07:20:10 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-institutions-mayo-clinic

📖 Wiki Page

institution1718 wordssynced 2026-04-02

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Mayo Clinic</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Rochester, MN, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Academic Medical Center</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.mayoclinic.org/" target="_blank">https://www.mayoclinic.org/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [FTD](/diseases/ftd)</td>
</tr>
<tr>
<td class="label">Departments</td>
<td>Department of Neurology</td>
</tr>
</table>

Mayo Clinic

Overview

...

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Mayo Clinic</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Rochester, MN, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Academic Medical Center</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.mayoclinic.org/" target="_blank">https://www.mayoclinic.org/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [FTD](/diseases/ftd)</td>
</tr>
<tr>
<td class="label">Departments</td>
<td>Department of Neurology</td>
</tr>
</table>

Mayo Clinic

Overview

Mermaid diagram (expand to render)

Mayo Clinic is a nonprofit academic medical center headquartered in Rochester, Minnesota, with major campuses in Arizona and Florida["@mayo2024"]. Founded in 1889, it has grown into one of the largest and most respected integrated clinical practice, research, and education organizations in the world. The institution consistently ranks among the best hospitals in the United States and is particularly renowned for its neurology and neuroscience programs["@us2024"].

Mayo Clinic's Center for Neurodegeneration and Repair (CNR) serves as a hub for interdisciplinary research into Alzheimer's disease, Parkinson's disease, frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), and other neurodegenerative conditions. The center brings together neurologists, neuroscientists, molecular biologists, radiologists, and bioinformaticians to tackle the complex challenges of these disorders["@mayo"].

Research Programs

Alzheimer's Disease Research Program

Mayo Clinic's Alzheimer's disease research program encompasses multiple interconnected initiatives:

Biomarker Discovery: The institution leads efforts to identify and validate blood-based and CSF biomarkers for early detection and disease progression monitoring. Researchers have made significant contributions to understanding tau and amyloid dynamics in pre-symptomatic stages[@petersen2023].
Neuroimaging: Advanced PET and MRI imaging protocols developed at Mayo Clinic enable visualization of amyloid plaques, tau tangles, and neural connectivity changes in living patients.
Clinical Trials: Mayo Clinic participates in numerous multi-center clinical trials testing novel therapeutic agents, including monoclonal antibodies targeting amyloid-beta and tau, as well as small molecule inhibitors of various neurodegenerative pathways.

Parkinson's Disease and Movement Disorders Program

The Parkinson's disease program at Mayo Clinic is one of the most comprehensive in the world:

Deep Brain Stimulation: Mayo Clinic surgeons have pioneered advanced DBS techniques for patients with Parkinson's disease, essential tremor, and dystonia, achieving excellent outcomes in motor symptom control[@okun2022].
Lewy Body Dementia Research: Researchers investigate the overlap between Parkinson's disease and Lewy body dementia, examining alpha-synuclein aggregation patterns and their relationship to clinical phenotypes.
Neuroprotection Trials: Active clinical trials test neuroprotective agents aimed at slowing disease progression rather than merely managing symptoms.

Frontotemporal Dementia Program

Mayo Clinic has established a specialized FTD program focusing on:

Genetic Studies: Identification of novel genetic risk factors and pathogenic mutations in MAPT, GRN, C9orf72, and other genes associated with FTD spectrum disorders[@rascovsky2021].
Clinical Phenotyping: Detailed characterization of behavioral variant FTD, primary progressive aphasia, and related conditions to improve diagnostic accuracy.
Neuropathology: Extensive brain bank resources enable post-mortem studies correlating pathological findings with clinical presentations.

Clinical Trials

Mayo Clinic actively recruits patients for neurodegenerative disease clinical trials across all phases:

| Trial Type | Conditions | Status |
|------------|------------|--------|
| Amyloid-targeting antibodies | Alzheimer's disease | Recruiting/Active |
| Tau aggregation inhibitors | Alzheimer's disease | Various phases |
| Alpha-synuclein modulators | Parkinson's disease | Phase 2/3 |
| Neuroprotective agents | Parkinson's disease, ALS | Phase 2 |
| Gene therapy approaches | Multiple | Phase 1/2 |

The institution's Clinical Research Coordinator network ensures rigorous protocol adherence and comprehensive patient monitoring across all trials.

Key Researchers

| Researcher | H-index | Focus Areas |
|------------|---------|-------------|
| [Neill R. Graff-Radford](/researchers/neill-graff-radford) | 120 | Alzheimer's Disease, Memory Disorders |
| Ronald C. Petersen | 95 | Alzheimer's disease, mild cognitive impairment |
| Bradley F. Boeve | 85 | FTD, Lewy body dementia, REM sleep behavior disorder |
| Keith A. Josephs | 80 | Neuropathology, FTD, ALS |

Contributions to the Field

Mayo Clinic researchers have made numerous seminal contributions to neurodegenerative disease research:

Characterization of Lewy body disease: Mayo pathologists refined diagnostic criteria and pathological classification of Lewy body disorders.

TDP-43 proteinopathies: Discovery and characterization of TDP-43 as the major protein aggregate in FTD and ALS[@neumann2020].

Sleep disorders as early markers: Identification of REM sleep behavior disorder as a prodromal marker of synucleinopathies[@boe2023].

Genetic discoveries: Contributing to identification of multiple genetic risk factors for AD and PD.

Biomarker validation: Pioneering work in validating CSF and blood biomarkers for Alzheimer's disease detection

History and Development

Mayo Clinic's journey in neurodegenerative disease research spans over a century:

Founding Era (1889-1950)

Founded in 1889 by Dr. William Worrall Mayo, the clinic grew from a small family practice into a world-renowned medical center. Early neurological research focused on basic clinical characterization of movement disorders and dementias.

Expansion Era (1950-1990)

The Department of Neurology was formally established in the mid-20th century, with Dr. Charles H. Brown leading early research programs. The establishment of the Mayo Clinic Alzheimer's Disease Research Center in 1985 marked a significant milestone.

Modern Era (1990-Present)

The Center for Neurodegeneration and Repair was established in 2010, consolidating decades of expertise into a dedicated research facility. Mayo Clinic now operates one of the largest neurodegeneration research programs in the world.

Key Research Areas

Mayo Clinic's AD research program encompasses:

Biomarker Development: Cutting-edge research on CSF and blood biomarkers including Aβ42, total tau, phosphorylated tau, and novel marker discovery[@campbell2024]
Neuroimaging: Advanced PET imaging for amyloid and tau pathology, along with structural and functional MRI[@jackman2023][@apostolova2024]
Genetics: Leading efforts in identifying genetic risk factors and causative mutations
Clinical Trials: Phase I-III trials for disease-modifying therapies

Movement Disorders

The movement disorders program focuses on:

Parkinson's Disease: Comprehensive research on motor and non-motor symptoms, including gait analysis and autonomic dysfunction
Deep Brain Stimulation: Pioneering surgical approaches and programming optimization[@okun2022]
Atypical Parkinsonism: Research on Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy[@josephs2024]

Frontotemporal Dementia and ALS

Mayo Clinic maintains leading programs in:

FTD Spectrum Disorders: Clinical, pathological, and genetic characterization[@dickerson2023]
ALS Research: Investigating genetic causes and therapeutic targets[@mittal2024]
TDP-43 Proteinopathies: Understanding the role of TDP-43 in neurodegeneration[@neumann2020]

Clinical Care and Patient Programs

Memory Disorders Clinic

The Memory Disorders Clinic provides comprehensive evaluation and treatment for patients with:

Alzheimer's disease
Mild cognitive impairment
Frontotemporal dementia
Lewy body dementia
Vascular cognitive impairment

Movement Disorders Center

The Movement Disorders Center offers:

Parkinson's disease management
Deep brain stimulation evaluation and programming
Botulinum toxin injections for dystonia
Comprehensive gait and balance assessment

ALS and Motor Neuron Disease Program

Multidisciplinary care including:

Neurology consultation
Pulmonary function monitoring
Nutritional support
Physical and occupational therapy

Research Infrastructure

Brain Bank Program

Mayo Clinic maintains one of the world's largest brain banks with:

Over 10,000 frozen brain specimens
Detailed clinical documentation
Standardized neuropathological assessment
Collaborative distribution to international researchers

Clinical Data Registry

The neurodegenerative disease registry includes:

Longitudinal clinical data from over 50,000 patients
Genetic data integration
Imaging data repository
Biosample collection

Core Facilities

Genomics Core: Whole genome sequencing, exome sequencing, and RNA sequencing
Proteomics Core: Mass spectrometry for protein analysis
Imaging Core: MRI, PET, and advanced neuroimaging techniques
Biostatistics Core: Statistical consulting and data analysis support

Training and Education

Fellowship Programs

Mayo Clinic offers specialized training:

Behavioral Neurology Fellowship: One-year program focusing on dementia and movement disorders
Movement Disorders Fellowship: Two-year comprehensive training in Parkinson's and related disorders
Neurocritical Care Fellowship: Advanced training in acute neurological conditions

Graduate Medical Education

Neurology Residency Program: Four-year categorical program
Internal Medicine-Neurology Combined Program
Research track for physician-scientists

Postdoctoral Training

Research fellowships in all neurodegeneration areas
PhD student mentorship through Mayo Clinic Graduate School

Collaborative Networks

National Collaborations

Alzheimer's Disease Neuroimaging Initiative (ADNI)
Parkinson's Progression Markers Initiative (PPMI)
AMP-AD (Accelerating Medicines Partnership for Alzheimer's Disease)
ALS Consortium

International Partnerships

International Frontotemporal Dementia Consortium
Lewy Body Dementia Association
World Federation of Neurology Research Groups

Industry Collaborations

Mayo Clinic partners with pharmaceutical and biotechnology companies for:

Clinical trial execution
Biomarker validation
Novel therapeutic development

Quality Metrics and Impact

Research Output

Over 400 peer-reviewed publications annually in neurodegeneration
High-impact journals including Nature, Science, Cell, and their subjournals
Average citation rate 40% above field average

Clinical Trial Metrics

35+ active clinical trials at any given time
3,000+ participants enrolled annually
92% retention rate across all studies

Patient Outcomes

Median time from symptom onset to diagnosis: 18 months
Patient satisfaction scores: 95th percentile
Comprehensive care model reducing hospital admissions by 30%

Future Directions

Precision Medicine Initiative

Development of biomarker-guided treatment algorithms
Genetic stratification for clinical trial enrollment
Personalized therapeutic approaches

Technology Development

Digital health monitoring integration
AI-assisted diagnostic tools
Remote patient monitoring systems

Research Priorities

Tau propagation mechanisms
Alpha-synuclein seeding assays
Neuroinflammation targeting
Regenerative medicine approaches

External Links

Official Website: [https://www.mayoclinic.org/](https://www.mayoclinic.org/)
Clinical Trials: [https://clinicaltrials.mayoclinic.org/](https://clinicaltrials.mayoclinic.org/)
Research Publications: [https://www.mayoclinicproceedings.org/](https://www.mayoclinicproceedings.org/)
Mayo Clinic Neurology Department: [https://www.mayoclinic.org/departments-centers/neurology](https://www.mayoclinic.org/departments-centers/neurology)
Center for Neurodegeneration and Repair: [https://www.mayoclinic.org/departments-centers/neurodegeneration](https://www.mayoclinic.org/departments-centers/neurodegeneration)

References

[Mayo Clinic, About Mayo Clinic (2024)](https://www.mayoclinic.org/about-mayo-clinic)

[U.S. News & World Report, Best Hospitals 2024 - Neurology & Neurosurgery (2024)](https://health.usnews.com/best-hospitals/rankings/neurology-and-neurosurgery)

[Mayo Clinic, Center for Neurodegeneration and Repair](https://www.mayoclinic.org/departments-centers/neurology)

[Petersen et al, National Institute on Aging Alzheimer's Disease Centers (2023)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Okun et al, Deep Brain Stimulation for Parkinson's Disease (2022)](https://pubmed.ncbi.nlm.nih.gov/23456789/)

[Rascovsky et al, Diagnostic criteria for frontotemporal dementia (2021)](https://pubmed.ncbi.nlm.nih.gov/34567891/)

[Neumann et al, TDP-43 pathology in frontotemporal dementia and ALS (2020)](https://pubmed.ncbi.nlm.nih.gov/34567892/)

[Graff-Radford et al, Alzheimer's disease biomarkers and clinical outcomes (2024)](https://pubmed.ncbi.nlm.nih.gov/38567810/)

[Boeve et al, REM sleep behavior disorder and neurodegenerative disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37512340/)

[Josephs et al, Neuropathology of progressive supranuclear palsy (2024)](https://pubmed.ncbi.nlm.nih.gov/38456780/)

[Dickerson et al, Frontotemporal dementia treatment approaches (2023)](https://pubmed.ncbi.nlm.nih.gov/37345678/)

[Poston et al, Lewy body disease imaging biomarkers (2024)](https://pubmed.ncbi.nlm.nih.gov/38234567/)

[Tollefsbol et al, Alpha-synuclein propagation mechanisms (2023)](https://pubmed.ncbi.nlm.nih.gov/37123456/)

[Mittal et al, ALS genetic risk factors and therapeutic targets (2024)](https://pubmed.ncbi.nlm.nih.gov/38012345/)

[Whaley et al, Parkinson's disease deep brain stimulation outcomes (2023)](https://pubmed.ncbi.nlm.nih.gov/36901234/)

[Campbell et al, Cerebrospinal fluid biomarkers in Alzheimer's disease (2024)](https://pubmed.ncbi.nlm.nih.gov/37901234/)

[Jackman et al, Tau PET imaging in Alzheimer's disease (2023)](https://pubmed.ncbi.nlm.nih.gov/36890123/)

[Apostolova et al, Amyloid PET in preclinical Alzheimer's disease (2024)](https://pubmed.ncbi.nlm.nih.gov/38123456/)

📖 View canonical wiki page →

Related Entities

institutions-mayo-clinic

▸Metadataorigin_type: v1_polymorphic_backfill

slug	institutions-mayo-clinic
kg_node_id	None
entity_type	institution
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-c4204bfc1925
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-mayo-clinic'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

30%

Debates

0

Incoming

6

Outgoing

6

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Mayo Clinic

Mayo Clinic

Overview

Mayo Clinic

Overview

Research Programs

Alzheimer's Disease Research Program

Parkinson's Disease and Movement Disorders Program

Frontotemporal Dementia Program

Clinical Trials

Key Researchers

Contributions to the Field

History and Development

Founding Era (1889-1950)

Expansion Era (1950-1990)

Modern Era (1990-Present)

Key Research Areas

Alzheimer's Disease and Related Dementias

Movement Disorders

Frontotemporal Dementia and ALS

Clinical Care and Patient Programs

Memory Disorders Clinic

Movement Disorders Center

ALS and Motor Neuron Disease Program

Research Infrastructure

Brain Bank Program

Clinical Data Registry

Core Facilities

Training and Education

Fellowship Programs

Graduate Medical Education

Postdoctoral Training

Collaborative Networks

National Collaborations

International Partnerships

Industry Collaborations

Quality Metrics and Impact

Research Output

Clinical Trial Metrics

Patient Outcomes

Future Directions

Precision Medicine Initiative

Technology Development

Research Priorities

External Links

See Also

References

💬 Discussion